Anticholinesterase activity of compounds related to geneserine tautomers. N-oxides and 1,2-oxazines

Journal of Medicinal Chemistry

Volumn 45, Issue 17, 2002, Pages 3684-3691

  Yu, Qian sheng ^a   Zhu, Xiaoxiang ^a   Holloway, Harold W ^a   Whittaker, Noel F ^b   Brossi, Arnold ^c   Greig, Nigel H ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2' ETHYLPHENYLGENESERINE; 2' METHYLPHENYLGENESERINE; 4' ISOPROPYLPHENYLGENESERINE; ACETYLCHOLINESTERASE; CARBAMIC ACID DERIVATIVE; CHOLINESTERASE; ESERIDINE; OXAZINE DERIVATIVE; OXIDE; PHENYLGENESERINE; PHYSOSTIGMINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHOLINESTERASE INHIBITION; DRUG POTENCY; DRUG SELECTIVITY; HUMAN; ISOMERISM; OXIDATION; PH; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOSPECIFICITY; STRUCTURE ACTIVITY RELATION; TIME;

ACETYLCHOLINESTERASE; ALKALOIDS; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; CYCLIC N-OXIDES; HUMANS; ISOMERISM; OXAZINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037103378     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm010491d     Document Type: Article

References (36)

1. The ordeal bean of old Calabar: The pageant of Physostigma Venenosum in Medicine
2. Alkaoids of the Calabar bean
3. Alkaloids of physostigma venenosum part IX. The absolute configuration of geneserine; an application of the nuclear Overhauser effect
4. Indole alkaloids. XXI: A revised structure for geneserine
5. Geneserine and geneseroline revisited: Acid-base catalyzed equilibria of hexhydropyrolo-[2,3-b]-indole N-oxides with hexahydro-1,2-oxazino-[5,6-b]-indoles
6. Cholinesterase inhibitory activity and antiamnesic effevt of CHF 2819.01, a potential antidementia drug
7. Selective inhibition of acetyl- and butyrylcholinesterases by phenylcarbamates of(-)-eseroline, (-)-(N1)-noreseroline and physovenol
8. Phenserine and ring C hetero-analogues: Drug candidates for treatment of Alzheimer's disease
9. Invited review. Phenserine, a novel anticholinesterase related to physostigmine: Total synthesis and biological properties
10. A new therapeutic target in Alzheimer's disease treatment: Attention to butyrylcholinesesterase
11. Changes in brain cholinesterases in senile dementia of Alzheimer type
12. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
13. Cholinesterase inhibitors: A new class of psychotropic compounds
14. Cholinesterase inhibitors: From the Calabar bean to Alzheimer therapy
15. Geneserine hydrochoride
16. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease
17. Methyl analogues of the experimental Alzheimer drug, phenserine: Synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action
18. Cholinesterase inhibitory activity of new geneserine derivatives
19. Biochemical and neurobehavioural profile of CHF2819, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease
20. Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterase
21. Drug therapy: Drug disposition in old age
22. Aging and drug disposition: An update
23. The experimental Alzheimer drug phenserine: Pharmacodynamics and kinetics in the rat
24. Complex maze learning is improved in aged rats treated with novel and long-acting acetylcholinesterase inhibitors
25. Butyrylcholinesterase in the life cycle of amyloid plaques
26. Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia
27. Regulation of APP processing with cholinesterase inhibitors
28. Cholinesterase inhibitors, β-amyloid precursor protein and amyloid β-peptides in Alzheimer's disease
29. Phenserine regulates translation of β-amyloid precursor protein mRNA by a putative interleukin-1 responsive element: A novel target for drug development
30. Anticholinesterase profile of phenserine in healthy elderly human subjects
31. Brain selective inhibition of acetylcholinesterase: A novel approach to therapy of Alzheimer's disease